胰岛素抵抗代谢评分可预测银屑病关节炎患者的心血管疾病风险:来自为期10年前瞻性CARMA队列的结果
基于西班牙前瞻性CARMA项目,纳入500例无心血管事件、慢性肾脏病、糖尿病或他汀使用史的银屑病关节炎患者,随访10年。随访4788患者年期间27人发生至少一次心血管事件,年发病率为5.6/1000患者年(95%CI 3.7至8.2)。发生心血管事件者METS-IR评分显著高于未发生者(2.37±0.24 vs 2.26±0.19;p=0.01),基线METS-IR>2.48者随访期间发生心血管事件风险增加。
要点
- 发生心血管事件的PsA患者METS-IR评分显著高于未发生者(2.37±0.24 vs 2.26±0.19;p=0.01)。
- 发生心血管事件者更多位于METS-IR 2.25-2.48和>2.48类别(p=0.008)。
- 基线METS-IR>2.48的PsA患者随访期间心血管事件风险增加。
核心结论
- 在纳入前瞻性CARMA项目的风湿科密切观察的PsA患者中,METS-IR可作为心血管事件的可靠预后预测指标。
研究设计与样本
- 评估纳入西班牙前瞻性CARMA(风湿病学心血管)项目的PsA患者,分析基线时无心血管事件史、慢性肾脏病、糖尿病或他汀使用史的500例PsA患者的基线数据,在三级中心风湿科门诊前瞻性随访10年,评价METS-IR预测心血管事件的表现,并将METS-IR分为<2.25、2.25-2.48和>2.48三组。
主要发现
- 随访4788患者年期间,27人发生至少一次心血管事件,年发病率为5.6/1000患者年(95%CI 3.7至8.2)。
- 发生心血管事件的PsA患者METS-IR评分显著高于未发生心血管事件者(2.37±0.24 vs 2.26±0.19;p=0.01)。
- 发生心血管事件者更多位于METS-IR 2.25-2.48和>2.48类别(p=0.008)。
- 校正回归模型显示,基线METS-IR>2.48的PsA患者随访期间发生心血管事件风险增加。
关键数值与推荐
- METS-IR分组:<2.25、2.25-2.48和>2.48。
- 发生心血管事件者METS-IR为2.37±0.24,未发生者为2.26±0.19(p=0.01)。
- 心血管事件年发病率为5.6/1000患者年(95%CI 3.7至8.2)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the predictive value of the metabolic score for insulin resistance (METS-IR) in identifying patients with psoriatic arthritis (PsA) at high risk of cardiovascular (CV) events. METHODS: Assessment of patients with PsA enrolled in the Spanish prospective CARdiovascular in ReuMAtology (CARMA) project. Baseline data from 500 PsA patients without a history of CV events, chronic kidney disease, diabetes mellitus or statin use at the baseline visit were analysed. Patients were prospectively followed for 10 years in rheumatology outpatient clinics at tertiary centres. The performance of the METS-IR in predicting CV events was evaluated. METS-IR was categorised into three groups: <2.25, 2.25-2.48 and >2.48. RESULTS: Over 4788 patient-years of follow-up, 27 individuals experienced at least one CV event. The annualised incidence rate was 5.6 events per 1000 patient-years (95% CI: 3.7 to 8.2). PsA patients with CV events had significantly higher METS-IR scores than those without CV events (2.37±0.24 vs 2.26±0.19; p=0.01). In this regard, patients who had CV events were more commonly included in the METS-IR 2.25-2.48 and >2.48 categories than those without CV events (p=0.008). Adjusted regression models indicated that PsA patients with a METS-IR >2.48 at baseline had an increased risk of experiencing a CV event during the follow-up period. CONCLUSIONS: In PsA patients under close observation in rheumatology units included in the prospective CARMA project, METS-IR serves as a reliable prognostic predictor of CV.
引用
- Gonzalez-Gay MA, Ferraz-Amaro I, Castañeda S, et al. The metabolic score for insulin resistance predicts the risk of cardiovascular disease in patients with psoriatic arthritis: results from the 10-year prospective CARMA cohort. RMD Open. 2025. PMID: 40055002. doi:10.1136/rmdopen-2024-005352
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。